Latham John A

Avg. Two Year Performance

No purchase track record

38% Avg. Sale Return

17% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	5%	6%	14%	28%	38%
Sale Success Rate	18 of 24	16 of 24	17 of 24	16 of 24	18 of 24

Alder Biopharmaceuticals Inc

Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 244.18K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--